📊 This is a profile preview from the Tablestat.com Platform Request a Free Trial Now

Life Sciences Clinical Trial Software sector

Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Clinical Trial Software

1.1 - About Life Sciences Clinical Trial Software sector

Companies in the Life Sciences Clinical Trial Software category provide digital platforms to plan, execute, and oversee clinical studies across sponsors, CROs, and research sites. They centralize protocol design, site activation, participant enrollment, data capture, and compliance workflows to reduce timelines and risk. M&A teams seeking strategic buyers in clinical trials technology will find vendors focused on interoperable, audit-ready operations and end-to-end study orchestration.

These providers typically offer clinical trial management systems to coordinate study operations, electronic data capture with edit checks and SDTM mapping, ePRO/eCOA for patient outcomes, randomization and trial supply management to control arms and inventory, and eConsent with investigator portals to streamline site workflows. They also deliver study start-up and feasibility tools, patient recruitment and engagement solutions, and risk-based monitoring analytics with remote SDV, safety/EHR integrations, and compliant audit trails.

Primary customers include biopharma sponsors, contract research organizations, and medical device manufacturers. Their platforms help accelerate enrollment and start-up, improve data quality and protocol compliance, reduce operational costs through automation, and shorten study cycle times. They strengthen oversight across multi-site trials, enable real-time visibility for study teams, and support regulatory readiness under ICH-GCP with standardized processes and comprehensive documentation.

2. Buyers in the Life Sciences Clinical Trial Software sector

2.1 Top strategic acquirers of Life Sciences Clinical Trial Software companies

Verily Logo

Verily

HQ: United States Website
  • Description: Provider of precision health technology that makes healthcare data AI-ready through curation, analytics and virtual care; delivering tools for biomedical research, clinical trial management, chronic-condition support and population-level disease monitoring so pharma, health systems, payers and employers can accelerate discoveries, launch therapies faster and improve outcomes at lower cost.
  • Key Products:
  • Study Watch: Wearable device capturing continuous physiological signals and supporting virtual motor exams, generating longitudinal digital measures for remote clinical research insights
  • Verily Workbench: Cloud environment allowing researchers to manage, cross-reference and analyze large-scale biomedical datasets, including Parkinson’s molecular data
  • Immune Profiler Xseq: Proprietary sequencing service delivering 30X whole-genome, cytokine, metabolomic and α-synuclein profiling to build high-resolution molecular datasets
  • Precision Research Solutions: Integrated AI-driven analytics and data science tools that accelerate clinical studies and personalize care pathways across healthcare applications.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Life Sciences Clinical Trial Software sector

Description: Companies in the Life Sciences Trial Recruitment Platforms category build technology and services to identify, engage, and qualify eligible patients for clinical studies. They aggregate data from EHRs, registries, and digital channels, orchestrate privacy-compliant outreach, and streamline prescreening and consent. The value proposition is faster enrollment, improved cohort quality, and greater participant diversity, reducing timeline risk and overall study cost for sponsors, CROs, and research sites.
SubjectWell

SubjectWell

HQ: United States
  • Type: N/A
  • Employees: ●●●●●
  • Description: Provider of a patient recruitment and experience platform that connects clinical trials with eligible participants, offering a risk-free clinical trial marketplace, guided recruitment, virtual waiting rooms, and full-service agency support to drive predictable enrollment and retention for sponsors, CROs, and research sites.
  • Key Products:
  • Patient-Centric Technology Platform: End-to-end recruitment engine using a 13 M+ patient network to identify, engage, and enroll trial candidates across 102 countries, reducing time and cost for sponsors
  • Multilingual Patient & Site Companions: Clinically trained staff provide multilingual support to patients and sites, guiding screening, consent, and retention processes to ease site workload and improve participant experience
  • Global Digital Media Network: Extensive digital advertising ecosystem distributes targeted trial messaging on channels like Facebook
  • TikTok, and Google to reach diverse, hard-to-find patient populations quickly and cost-effectively
  • OneView Recruitment Visibility Platform: Real-time dashboard tracks referrals, monitors funnel metrics, and flags bottlenecks, giving sponsors
  • CROs, and sites actionable insights that accelerate enrollment and lower site burden.
🔒
🔒
🔒
🔒
🔒
🔒
🔒 View all 3 companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms in Life Sciences Clinical Trial Software sector

3.1 - Buyout funds in the Life Sciences Clinical Trial Software sector

Buyout Funds investing in Life Sciences Clinical Trial Software companies

51+ funds
Description: Buyout funds focused on Life Sciences Clinical Trial Software companies globally.

Astorg

Website HQ: France
  • Type: Buyout
  • Fund Size: $●●●m
  • Investment Range: $●●-●●●m
  • Focus: Technology companies in Life Sciences Clinical Trial Software
  • Relevant M&A transactions / similar portfolio companies:
🔒
🔒
🔒
🔒
🔒
🔒

2.2 - Strategic buyer groups for Life Sciences Clinical Trial Software sector

Growth Equity Funds in Life Sciences Clinical Trial Software companies

41+ funds
Description: Growth equity funds focused on Life Sciences Clinical Trial Software companies globally.

Idinvest Partners

Website HQ: France
  • Type: Growth
  • Fund Size: $●●●m
  • Investment Range: $●●-●●●m
  • Focus: High-growth companies in Life Sciences Clinical Trial Software
  • Relevant investments / similar portfolio companies:
🔒
🔒
🔒
🔒
🔒
🔒
🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Life Sciences Clinical Trial Software companies

4.2 - Public trading comparable groups for Life Sciences Clinical Trial Software sector

Valuation benchmark group 1: Industry-Specific SaaS Companies

13 companies View group →
Description: Companies in this public trading comparables group provide industry‑specific, mission‑critical software delivered primarily via the cloud. Their business model centers on recurring subscription revenue augmented by maintenance and professional services, and in some cases hardware-enabled platforms. They are grouped as valuation benchmarks because they address vertical workflows with high switching costs, durable customer relationships, and predictable growth profiles typical of vertical market software.
Constellation Software logo

Constellation Software

  • Enterprise value: $●●●m
  • Market Cap: $●●●m
  • EV/Revenue: ●.●x
  • EV/EBITDA: ●●.●x
  • Description: Provider of software and services to public and private sector markets, specializing in acquiring, managing, and building industry-specific software businesses that offer mission-critical solutions to meet unique customer needs.
  • Key Products:
  • Vertical Market Software: Industry-specific software tailored to meet unique sector needs
  • Mission-Critical Solutions: Software that addresses essential business operations
  • Managed Services: Comprehensive management of software and IT infrastructure
  • Software Licensing: Licensing solutions for various industries
  • System Integration: Integration of disparate systems for seamless operations
🔒
🔒
🔒
🔒
🔒
🔒
🔒 View all 13 companies in this group
Request Free Trial Now →
🔒
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions in the Life Sciences Clinical Trial Software sector

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

Buyers & Acquirers in Life Sciences Clinical Trial Software sector

Who are the top strategic acquirers of Life Sciences Clinical Trial Software companies?

Top strategic buyers in this sector include Verily, a provider of precision health technology that makes healthcare data ai-ready through curation, analytics and virtual care; delivering tools for biomedical research, clinical trial management, chronic-condition support and population-level disease monitoring so pharma, health systems, payers and employers can accelerate discoveries, launch therapies faster and improve outcomes at lower cost. .

Which buyer groups are most relevant for Life Sciences Clinical Trial Software companies?

Relevant strategic buyer groups similar to the Life Sciences Clinical Trial Software sector include Clinical Trial Patient Recruitment because they share similar customer segments and product capabilities.

Financial Investors in Life Sciences Clinical Trial Software sector

Which are the top PE firms investing in Life Sciences Clinical Trial Software companies?

Potential investors in the broader Life Sciences Clinical Trial Software space include Idinvest Partners and Astorg.

Who are the top buyout funds acquiring Life Sciences Clinical Trial Software companies?

Active PE funds and buyout funds acquiring companies in the Life Sciences Clinical Trial Software space include Astorg.

Who are the top growth equity funds investing in Life Sciences Clinical Trial Software companies?

Growth funds investing in the broader Life Sciences Clinical Trial Software sector include Idinvest Partners.

Valuation of Companies in Life Sciences Clinical Trial Software sector

Which are the key public companies that are relevant trading comps for Life Sciences Clinical Trial Software companies?

Key trading comparable groups include Constellation Software, a provider of software and services to public and private sector markets, specializing in acquiring, managing, and building industry-specific software businesses that offer mission-critical solutions to meet unique customer needs..

Which are the key trading comparable groups for Life Sciences Clinical Trial Software companies?

Similar trading comparable companies include Industry-Specific SaaS Companies. Our platform tracks detailed trading comparable groups in the Life Sciences Clinical Trial Software sector with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in the Life Sciences Clinical Trial Software sector?

Our platform tracks M&A transactions in the Life Sciences Clinical Trial Software sector with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Life Sciences Clinical Trial Software?

Access recent funding rounds in the Life Sciences Clinical Trial Software sector including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors, valuations, and use of proceeds.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Life Sciences Clinical Trial Software

Launch login modal Launch register modal